These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32376391)

  • 1. The molecular basis of selective DNA binding by the BRG1 AT-hook and bromodomain.
    Sanchez JC; Zhang L; Evoli S; Schnicker NJ; Nunez-Hernandez M; Yu L; Wereszczynski J; Pufall MA; Musselman CA
    Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194566. PubMed ID: 32376391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of the functional roles of the Q and I motifs in the human chromatin-remodeling enzyme BRG1.
    Hoffmeister H; Fuchs A; Strobl L; Sprenger F; Gröbner-Ferreira R; Michaelis S; Hoffmann P; Nazet J; Merkl R; Längst G
    J Biol Chem; 2019 Mar; 294(9):3294-3310. PubMed ID: 30647132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.
    Singh M; Popowicz GM; Krajewski M; Holak TA
    Chembiochem; 2007 Jul; 8(11):1308-16. PubMed ID: 17582821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes.
    Morrison EA; Sanchez JC; Ronan JL; Farrell DP; Varzavand K; Johnson JK; Gu BX; Crabtree GR; Musselman CA
    Nat Commun; 2017 Jul; 8():16080. PubMed ID: 28706277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-binding properties of the recombinant high-mobility-group-like AT-hook-containing region from human BRG1 protein.
    Singh M; D'Silva L; Holak TA
    Biol Chem; 2006; 387(10-11):1469-78. PubMed ID: 17081121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the BRK domain of the SWI/SNF chromatin remodeling complex subunit BRG1 reveals a potential role in protein-protein interactions.
    Allen MD; Bycroft M; Zinzalla G
    Protein Sci; 2020 Apr; 29(4):1047-1053. PubMed ID: 31909846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting BRG1 chromatin remodeler via its bromodomain for enhanced tumor cell radiosensitivity in vitro and in vivo.
    Kwon SJ; Lee SK; Na J; Lee SA; Lee HS; Park JH; Chung JK; Youn H; Kwon J
    Mol Cancer Ther; 2015 Feb; 14(2):597-607. PubMed ID: 25504753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico screening of cancer-associated mutations in the HSA domain of BRG1 and its role in affecting the Arp-HSA sub-complex of SWI/SNF.
    S AS; Goutham R N A; Mohan S S
    Comput Biol Chem; 2018 Dec; 77():109-115. PubMed ID: 30286321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.
    Shen W; Xu C; Huang W; Zhang J; Carlson JE; Tu X; Wu J; Shi Y
    Biochemistry; 2007 Feb; 46(8):2100-10. PubMed ID: 17274598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Structural Model of the Endogenous Human BAF Complex Informs Disease Mechanisms.
    Mashtalir N; Suzuki H; Farrell DP; Sankar A; Luo J; Filipovski M; D'Avino AR; St Pierre R; Valencia AM; Onikubo T; Roeder RG; Han Y; He Y; Ranish JA; DiMaio F; Walz T; Kadoch C
    Cell; 2020 Oct; 183(3):802-817.e24. PubMed ID: 33053319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De-regulated expression of the BRG1 chromatin remodeling factor in bone marrow mesenchymal stromal cells induces senescence associated with the silencing of NANOG and changes in the levels of chromatin proteins.
    Squillaro T; Severino V; Alessio N; Farina A; Di Bernardo G; Cipollaro M; Peluso G; Chambery A; Galderisi U
    Cell Cycle; 2015; 14(8):1315-26. PubMed ID: 25724006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
    Medina PP; Sanchez-Cespedes M
    Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ATPase BRG1/SMARCA4 is a protein interaction platform that recruits BAF subunits and the transcriptional repressor REST/NRSF in neural progenitor cells.
    Jayaprakash S; Drakulic S; Zhao Z; Sander B; Golas MM
    Mol Cell Biochem; 2019 Nov; 461(1-2):171-182. PubMed ID: 31428904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAF complexes facilitate decatenation of DNA by topoisomerase IIα.
    Dykhuizen EC; Hargreaves DC; Miller EL; Cui K; Korshunov A; Kool M; Pfister S; Cho YJ; Zhao K; Crabtree GR
    Nature; 2013 May; 497(7451):624-7. PubMed ID: 23698369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal activity-induced BRG1 phosphorylation regulates enhancer activation.
    Kim B; Luo Y; Zhan X; Zhang Z; Shi X; Yi J; Xuan Z; Wu J
    Cell Rep; 2021 Jul; 36(2):109357. PubMed ID: 34260936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM-mediated phosphorylation of the chromatin remodeling enzyme BRG1 modulates DNA double-strand break repair.
    Kwon SJ; Park JH; Park EJ; Lee SA; Lee HS; Kang SW; Kwon J
    Oncogene; 2015 Jan; 34(3):303-13. PubMed ID: 24413084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterocomplex formation by Arp4 and β-actin is involved in the integrity of the Brg1 chromatin remodeling complex.
    Nishimoto N; Watanabe M; Watanabe S; Sugimoto N; Yugawa T; Ikura T; Koiwai O; Kiyono T; Fujita M
    J Cell Sci; 2012 Aug; 125(Pt 16):3870-82. PubMed ID: 22573825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers.
    Schick S; Rendeiro AF; Runggatscher K; Ringler A; Boidol B; Hinkel M; Májek P; Vulliard L; Penz T; Parapatics K; Schmidl C; Menche J; Boehmelt G; Petronczki M; Müller AC; Bock C; Kubicek S
    Nat Genet; 2019 Sep; 51(9):1399-1410. PubMed ID: 31427792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HSA domain of BRG1 mediates critical interactions required for glucocorticoid receptor-dependent transcriptional activation in vivo.
    Trotter KW; Fan HY; Ivey ML; Kingston RE; Archer TK
    Mol Cell Biol; 2008 Feb; 28(4):1413-26. PubMed ID: 18086889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long noncoding RNA protects the heart from pathological hypertrophy.
    Han P; Li W; Lin CH; Yang J; Shang C; Nuernberg ST; Jin KK; Xu W; Lin CY; Lin CJ; Xiong Y; Chien H; Zhou B; Ashley E; Bernstein D; Chen PS; Chen HV; Quertermous T; Chang CP
    Nature; 2014 Oct; 514(7520):102-106. PubMed ID: 25119045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.